Acute Porphyria Drugs

Monograph

D07XC01 - Betamethasone
Not porphyrinogenic
NP

Rationale
The glucocorticoid and ASA components are stated in several references not to be porphyrinogenic. Probably only insignificant systemic exposure.
Chemical description
Strong glucocorticoid 0.5 mg/g in combination with acetylsalicylic acid. Ointment used in steroide sensitive dermatoses. Glucocorticoid : South African list: use. Kalman, Bonkovsky: believed to be safe. The Merck Manual: safe. Tschudy DP, Lamon JM: Porphyrin metabolism and the Porphyrias in Bondy BK, Rosenberg LE (eds): Duncan’s Diseases of Metabolism, Philadelphia, WB Saunders 1980, p 939: safe. Moore MR, Hift RJ: Drugs in acute porphyria. Cell Mol Biol 43:89, 1997: safe. Acetylsalicylic acid: South African list: safe. Kalman, Bonkovsky: safe. Michael Moore’s list: safe. The Merck Manual: safe . Eales L: Porphyria and the dangerous lifethreatening drugs, S Afr Med 56:914, 1979: safe.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes D07X / D07XC or go back.
References
Tradenames

Diprosalic Diprosalic · Lotriderm Alergical · Cuatrocrem · Diprosalic · Syracerin Diprosalic Diprosalic · sal-Ekarzin Belasone · Diprosalic Betamethasone / Coal tar · Betamethasone / Ichthammol · Betesil · Chelsea cream Betamethason / Salicylsyre · Diprosalic · Diprosalinova Diprosalic Bedicort salic · Belosalic · Diprosalic · Salbetan · Triderm Diprosalic · Lotriderm Diprosalic Diprosalic Bedikertal Belosalic · Diprosalic Belosalic · Diprosalic · Flosteron · Kuterid
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙